Clinical Trial Update: An Open-Label Study of the Effects of Desloratadine (Aerius.) Treatment on the Quality of Life of Patients With Chronic Idiopathic Urticaria (Study P02540) [Phase 4]

View source ↗

Summary

Phase 4 open-label study assessing desloratadine's effect on quality of life in chronic idiopathic urticaria patients; completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Urticaria

Drugs mentioned

• Desloratadine (desloratadine)

Snippet

Sponsor: Organon and Co | Conditions: Urticaria | Phase 4 | Status: COMPLETED